Yunnan Jianzhijia Health Chain Stock Revenue
| 605266 Stock | 26.34 0.36 1.35% |
Yunnan Jianzhijia Health Chain fundamentals help investors to digest information that contributes to Yunnan Jianzhijia's financial success or failures. It also enables traders to predict the movement of Yunnan Stock. The fundamental analysis module provides a way to measure Yunnan Jianzhijia's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Yunnan Jianzhijia stock.
| Last Reported | Projected for Next Year | ||
| Total Revenue | 9.1 B | 9.5 B |
Yunnan | Revenue |
Yunnan Jianzhijia Health Chain Company Revenue Analysis
Yunnan Jianzhijia's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current Yunnan Jianzhijia Revenue | 9.08 B |
Most of Yunnan Jianzhijia's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Yunnan Jianzhijia Health Chain is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Historical and Projected quarterly revenue of Yunnan
Projected quarterly revenue analysis of Yunnan Jianzhijia provides investors and stakeholders with an insight into the company's performance and growth prospects. When actual revenues of Yunnan Jianzhijia match or exceed analyst estimates, it positively influences investor confidence and market perception, often leading to a rise in Yunnan Jianzhijia's stock price.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
Yunnan Current Deferred Revenue
Current Deferred Revenue |
|
Based on the latest financial disclosure, Yunnan Jianzhijia Health Chain reported 9.08 B of revenue. This is 19.06% higher than that of the Consumer Staples Distribution & Retail sector and significantly higher than that of the Consumer Staples industry. The revenue for all China stocks is 3.75% higher than that of the company.
Yunnan Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Yunnan Jianzhijia's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Yunnan Jianzhijia could also be used in its relative valuation, which is a method of valuing Yunnan Jianzhijia by comparing valuation metrics of similar companies.Yunnan Jianzhijia is currently under evaluation in revenue category among its peers.
Yunnan Fundamentals
| Return On Equity | 0.0862 | ||||
| Return On Asset | 0.0259 | ||||
| Profit Margin | 0.03 % | ||||
| Operating Margin | 0.05 % | ||||
| Current Valuation | 7.54 B | ||||
| Shares Outstanding | 156.66 M | ||||
| Shares Owned By Insiders | 50.79 % | ||||
| Shares Owned By Institutions | 20.92 % | ||||
| Price To Book | 1.49 X | ||||
| Price To Sales | 0.43 X | ||||
| Revenue | 9.08 B | ||||
| Gross Profit | 2.69 B | ||||
| EBITDA | 487.02 M | ||||
| Net Income | 414.41 M | ||||
| Total Debt | 749.61 M | ||||
| Book Value Per Share | 17.72 X | ||||
| Cash Flow From Operations | 1.02 B | ||||
| Earnings Per Share | 1.53 X | ||||
| Target Price | 68.33 | ||||
| Number Of Employees | 16.65 K | ||||
| Beta | 0.96 | ||||
| Market Capitalization | 4.04 B | ||||
| Total Asset | 9.95 B | ||||
| Retained Earnings | 1.27 B | ||||
| Working Capital | (922.54 M) | ||||
| Annual Yield | 0.05 % | ||||
| Net Asset | 9.95 B | ||||
| Last Dividend Paid | 1.07 |
About Yunnan Jianzhijia Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Yunnan Jianzhijia Health Chain's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Yunnan Jianzhijia using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Yunnan Jianzhijia Health Chain based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Yunnan Stock
Yunnan Jianzhijia financial ratios help investors to determine whether Yunnan Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Yunnan with respect to the benefits of owning Yunnan Jianzhijia security.